Out of 30 cross‑vertical startups, Amarastesia’s CerAMvix was awarded InnovX’s top innovation prize by a panel of investors, mentors,...

The USPTO’s Notice of Allowance confirms there was no prior art to challenge any of our 24 claims — a rare validation that highlights...

Amarastesia celebrates another milestone with a written notification from the EPO on the patentability of cerA&Mvix. While filing a...

Dr. Roxana Belciu Kerns, Aesthetic Physician with over 15 years of experience as Expert Injector and Medical Director of Orchid...

In the light of cadaveric testing for cerA&Mvix, Amarastesia has partnered with the Human Anatomy Laboratory of RUSH UNIVERSITY MEDICAL...

https://www.linkedin.com/posts/amarastesia_arpah-arpaneth-medtech-activity-7252779864410251264-wSoS?utm_source=share&utm_medium=member_de...

Through a project sponsored by INNOCHEQUE and INNOSUISSE, Amarastesia is partnering with the engineering department of HE-ARC University,...

AMARASTESIA's innovative approach has been recognized and its being supported by Innosuisse with a grant for ongoing coaching and...

https://www.linkedin.com/posts/amarastesia_amarastesia-and-ceramvix-a-game-changer-activity-7253796870353784833-jPbt?utm_source=share&utm...

https://www.linkedin.com/posts/dayone-healthcare-innovation_innovateinbasel-dayone-shapingthefutureofhealth-activity-7244722323927232513-...

A prior art search was completed to assess the likelihood that the disposable cervical dilator might encounter freedom to operate issues....

Disposable pass through dilator and method of use: US-11904122-B1 A disposable medical device, cervical dilator to dilate free of trauma...

CerA&Mvix, developed by Amarastesia, is pioneering the concept of Safe Instrument Passageway and essential Direct Visualization within an...